Candida auris and endogenous panophthalmitis: clinical and histopathological features

Mark P Breazzano1,2,3, Andrea A Tooley1,2,3,4,5, Kyle J Godfrey1,2,3,4

  • 1Lenox Hill Hospital, Northwell Health, New York, NY, USA.

Abstract

Insights

This case report details a fatal instance of endogenous panophthalmitis caused by Candida auris and Pseudomonas aeruginosa in an immunocompromised patient. It highlights the emerging threat of Candida auris in severe ocular infections.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Mycology

Background:

  • Candida auris is an emerging multidrug-resistant fungal pathogen causing invasive infections globally.
  • Endogenous panophthalmitis is a severe intraocular infection with poor visual prognosis.

Observation:

  • A 30-year-old immunocompromised male presented with polymicrobial endogenous panophthalmitis.
  • Ocular specimens revealed simultaneous infection with Pseudomonas aeruginosa and Candida auris.

Findings:

  • Histopathology showed extensive polymorphonuclear infiltration across all ocular tissues.
  • Despite aggressive treatment including intravitreal injections and enucleation, the patient succumbed to the infection.

Implications:

  • This is the first reported case of Candida auris causing endogenous endophthalmitis/panophthalmitis.
  • Clinicians should consider Candida auris in immunocompromised patients with severe ocular infections, especially those with a history of multi-center care.
  • The rising incidence of Candida auris necessitates heightened clinical suspicion and prompt management strategies.